Editor’s note

Filling the gaps in India’s pharma manufacturing supply chain

Read more

Why we need an Aatmanirbhar booster strategy

Read more

With Omicron, the SARS-CoV-2 virus ups the ante

Read more

The Covaxin-WHO EUL saga

Read more

Biocon Biologics-SII alliance should balance business and public health

Read more

Is India’s pharma sector being penalised for its success?

Read more

Not independent, but more inter-dependent than ever before

Read more

PharmEasy-Thyrocare deal milestone for e-pharmacy sector

Read more

Preparing for the third wave

Read more

No more the pharmacy/vaccine maker of the world?

Read more